{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:36:10Z","timestamp":1783427770170,"version":"3.54.6"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Taibah University Medical Sciences"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jtumed.2021.08.014","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T21:31:54Z","timestamp":1636407114000},"page":"72-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Formulation and evaluation of pH activated dosage form as minitablets in capsule for delivery of fesoterodine"],"prefix":"10.1016","volume":"17","author":[{"given":"Shoaeb M.","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratiksha V.","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran G.","family":"Gawale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipali C.","family":"Hamde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtumed.2021.08.014_bib1","first-page":"185","article-title":"Flexible-dose Fesoterodine in elderly adults with overactive bladder: results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trial","volume":"61","author":"Wagg","year":"2013"},{"issue":"5","key":"10.1016\/j.jtumed.2021.08.014_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.2042-7158.1979.tb13499.x","article-title":"Plasticization of cellulose ethers used in the film coating of tablets","volume":"31","author":"Entwistle","year":"1979","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"2","key":"10.1016\/j.jtumed.2021.08.014_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.jtumed.2021.08.014_bib4","first-page":"5","article-title":"Mini-tablet: a review","volume":"7","author":"Syed","year":"2016","journal-title":"Adv Bio Res"},{"issue":"7","key":"10.1016\/j.jtumed.2021.08.014_bib5","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4314\/tjpr.v13i7.3","article-title":"Formulation and evaluation of pH-responsive mini-tablets for ileo-colonic targeted drug delivery","volume":"13","author":"Mohd","year":"2014","journal-title":"Trop J Pharmaceut Res"},{"key":"10.1016\/j.jtumed.2021.08.014_bib6","first-page":"13","article-title":"Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain","author":"Sicras-Mainar","year":"2013","journal-title":"BMC Urol"},{"issue":"12","key":"10.1016\/j.jtumed.2021.08.014_bib7","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1517\/17425255.2013.858118","article-title":"Evaluation of fesoterodine fumarate for the treatment of an overactive bladder","volume":"9","author":"Mock","year":"2013","journal-title":"Expet Opin Drug Metabol Toxicol"},{"issue":"3","key":"10.1016\/j.jtumed.2021.08.014_bib8","first-page":"1448","article-title":"Formulation and in\u00a0vitro evaluation of fesoterodine fumarate sustained release tablets","volume":"5","author":"Krishna Reddy","year":"2018","journal-title":"Indo Am J Pharmaceut Sci"},{"key":"10.1016\/j.jtumed.2021.08.014_bib9","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.2147\/DDDT.S212520","article-title":"Physicochemical properties and drug-release mechanism of dual release bilayer tablet containing Mirabegron and Fesoterodine fumarate","volume":"13","author":"Lee","year":"2019","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"10.1016\/j.jtumed.2021.08.014_bib10","first-page":"116","article-title":"Formulation development and evaluation of delayed release Doxycycline","volume":"2","author":"Damodharan","year":"2010","journal-title":"Int J Pharm Pharmaceut Sci"},{"issue":"3","key":"10.1016\/j.jtumed.2021.08.014_bib11","first-page":"131","article-title":"Absorption of theophylline from conventional and sustained-release tablets","volume":"19","author":"Fagerstrom","year":"1981","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.jtumed.2021.08.014_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(01)00871-7","article-title":"An Enteric coated HPMC capsules designed to achieve intestinal targeting","volume":"231","author":"Cole","year":"2002","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.jtumed.2021.08.014_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0168-3659(03)00089-0","article-title":"Swelling and drug release behavior of minitablets coated with aqueous hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles","volume":"89","author":"Hyuk","year":"2003","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.jtumed.2021.08.014_bib14","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.3109\/03639048909052529","article-title":"The in\u00a0vitro and in\u00a0vivo performance of aqueous based enteric coats of neutralized hydroxypropyl methyl cellulose phthalate","volume":"15","author":"Bloor","year":"1989","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"10.1016\/j.jtumed.2021.08.014_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1081\/DDC-120003456","article-title":"Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and minitablet hardness on drug release using a 2(3) full factorial design","volume":"28","author":"Khanvilkar","year":"2002","journal-title":"Drug Dev Ind Pharm"},{"issue":"15","key":"10.1016\/j.jtumed.2021.08.014_bib16","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3109\/03639049409042643","article-title":"A\u00a0comparison of the dissolution characteristics of theophylline from film coated granules and mini-minitablets","volume":"20","author":"Munday","year":"1994","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.jtumed.2021.08.014_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5173(98)00327-5","article-title":"Aqueous ethyl cellulose dispersions containing plasticizers of different water solubility and hydroxypropyl methylcellulose as coating material for diffusion pellets Drug release rates from coated pellets","volume":"177","author":"Frohoff-H\u00fclsmann","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtumed.2021.08.014_bib18","first-page":"735","volume":"vol. 2","year":"1996"},{"issue":"1\u20132","key":"10.1016\/j.jtumed.2021.08.014_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2008.03.034","article-title":"A\u00a0novel approach to sustained pseudoephedrine release: differentially coated Mini- minitablets in HPMC capsules","volume":"359","author":"Ishida","year":"2008","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1016\/j.jtumed.2021.08.014_bib20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1464-410X.2010.09640.x","article-title":"Superior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head-to-head, placebo-controlled trial","volume":"107","author":"Steven","year":"2011","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.jtumed.2021.08.014_bib21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2144\/04375RV01","article-title":"Behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking","volume":"37","author":"Migneault","year":"2004","journal-title":"Biotechniques"},{"issue":"1","key":"10.1016\/j.jtumed.2021.08.014_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/10717544.2017.1279238","article-title":"pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms","volume":"24","author":"Liu","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jtumed.2021.08.014_bib23","first-page":"100061","article-title":"Tableting of mini-tablets in comparison with conventionally sized tablets: a comparison of tableting properties and tablet dimensions","volume":"2","author":"Ard","year":"2020","journal-title":"Int J Pharm X"},{"key":"10.1016\/j.jtumed.2021.08.014_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2008.03.034","article-title":"A\u00a0novel approach to sustained pseudoephedrine release:Differentially coated mini-tablets in HPMC capsules","volume":"359","author":"Ishida","year":"2008","journal-title":"Int J Pharm"}],"container-title":["Journal of Taibah University Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361221002055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361221002055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:30:30Z","timestamp":1761647430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1658361221002055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1658361221002055"],"URL":"https:\/\/doi.org\/10.1016\/j.jtumed.2021.08.014","relation":{},"ISSN":["1658-3612"],"issn-type":[{"value":"1658-3612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation and evaluation of pH activated dosage form as minitablets in capsule for delivery of fesoterodine","name":"articletitle","label":"Article Title"},{"value":"Journal of Taibah University Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtumed.2021.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}